Pliant Therapeutics (NASDAQ:PLRX) Downgraded by JPMorgan Chase & Co. to Neutral
JPMorgan Chase & Co. downgraded shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Monday, Marketbeat reports. PLRX has been the subject of several other research reports. HC Wainwright lowered Pliant Therapeutics from a “buy” rating to a “neutral” rating […]
JPMorgan Chase & Co. downgraded shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Monday, Marketbeat reports. PLRX has been the subject of several other research reports. HC Wainwright lowered Pliant Therapeutics from a “buy” rating to a “neutral” rating […]
